Comment on Chen et al. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin. <i>Biomolecules</i> 2021, <i>11</i>, 1373
In the study of Chen et al. [...]
Main Authors: | Nicolai Stransky, Stephan M. Huber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/4/573 |
Similar Items
-
Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin
by: Shaomeng Chen, et al.
Published: (2021-09-01) -
Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy
by: Ali Razaghi, et al.
Published: (2023-08-01) -
The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade
by: Yuchen Zhang, et al.
Published: (2024-11-01) -
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
by: Elizabeth Ahern, et al.
Published: (2018-06-01) -
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma
by: Michael A Curran, et al.
Published: (2024-10-01)